September 25, 2016 1:07 PM ET

Health Care Technology

Company Overview of DNAnexus, Inc.

Company Overview

DNAnexus, Inc. provides cloud-based genome informatics and data management tools for enterprises and organizations that are engaged in the development and delivery of genomic medicine. The company’s platform enables the companies to analyze raw sequencing data; integrate genomic data with clinical and other phenotypic data; and collaborate seamlessly. It serves biopharmaceutical companies, genome centers, diagnostic test providers, and others. The company has a strategic alliance with WuXi NextCODE Genomics. DNAnexus, Inc. was founded in 2009 and is based in Mountain View, California.

1975 West El Camino Real

Suite 101

Mountain View, CA 94040

United States

Founded in 2009

Phone:

650-969-3251

Fax:

415-268-7522

Key Executives for DNAnexus, Inc.

Chief Executive Officer and Director
Age: 66
Executive Chairman
Age: 58
Co-Founder and Board Observer
Co-Founder and Board Observer
Compensation as of Fiscal Year 2016.

DNAnexus, Inc. Key Developments

M2Gen Selects DNAnexus to Manage Molecular Data for ORIEN Avatar Research Program

DNAnexus Inc. announced that M2Gen has adopted the company’s cloud translational science platform to support molecular data access, management, collaboration, and analysis for the Oncology Research Information Exchange Network (ORIEN) Avatar Research Program. This initiative unites academic cancer centers and pharmaceutical companies in pursuit of shared translational oncology goals: the development of more precise cancer treatments for patients. The ORIEN Avatar Research Program provides a secure and innovative collaborative environment linking pharmaceutical companies, including Takeda and Celgene, and prominent cancer centers, including co-founders Moffitt Cancer Center in Tampa, Fla. and The Ohio State University Comprehensive Cancer Center "Arthur G. James Cancer Hospital and Richard J. Solove Research Institute in Columbus, Ohio. Participating cancer researchers contribute samples and disease information from consenting, participating patients, and receive rich molecular data plus access to a rich network of potential collaborators.

DNAnexus, Inc. Presents at UBS Genomics 2.0 Summit, Aug-11-2016 01:15 PM

DNAnexus, Inc. Presents at UBS Genomics 2.0 Summit, Aug-11-2016 01:15 PM. Venue: St. Regis Deer Valley, Park City, Utah, United States. Speakers: Brad Sitko, Vice President of Finance & Corporate Development, David Shaywitz, Chief Medical Officer.

DNAnexus Platform Supports Clinical Whole Genome Sequencing Service from Garvan Institute

DNAnexus Inc. announced that the Garvan Institute of Medical Research in Sydney, Australia has selected the DNAnexus Platform to power its new Genome.One clinical whole genome testing company. Garvan uses DNAnexus to manage, analyze, and secure the massive quantities of genomic data generated by the center’s leading NGS technology including Illumina’s HiSeq X Ten. Garvan uses the DNAnexus Platform to support complex, multi-institution global collaborations as well as high-speed, cost-efficient analysis and delivery of sequence data across a worldwide network. The Garvan Institute’s new company, Genome.One offers clinical whole-genome sequencing services for diagnosing rare and genetic conditions. Genome.One represents the clinical extension of the Kinghorn Centre for Clinical Genomics (KCCG), and benefits from the nearly 18-month relationship between DNAnexus and the Garvan Institute. Rather than traditional tests that analyze a single gene or multi-gene panel, this new service has the capacity to sequence and analyze the entire genome, including all 20,000 genes, in a single test. The new service provides a fast, accurate and comprehensive service, and is expected to increase the diagnosis rates of rare disorders from around twenty percent to 46%.

Similar Private Companies By Industry

Company Name Region
1747, Inc. United States
1EQ, Inc. United States
20over8, Inc. United States
21CT, Inc. United States
3AM Technologies, LLC United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Bloomberg L.P. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact DNAnexus, Inc., please visit www.dnanexus.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.